Top Page
Teijin
(OTC:3401)
Teijin (3401) vs. iShares MSCI Japan ETF (EWJ)
Teijin Business Overview & Revenue Model
Teijin Earnings Call Summary
Teijin Financial Statement Overview
| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.01T | 1.03T | 1.02T | 926.05B | 836.51B |
| Gross Profit | 191.45B | 275.77B | 248.14B | 271.02B | 255.00B |
| EBITDA | -67.71B | 118.08B | 84.36B | 113.02B | 106.77B |
| Net Income | 28.35B | 10.60B | -17.70B | 23.16B | -6.66B |
Balance Sheet | |||||
| Total Assets | 1.06T | 1.25T | 1.24T | 1.21T | 1.04T |
| Cash, Cash Equivalents and Short-Term Investments | 107.54B | 125.92B | 142.78B | 134.48B | 170.19B |
| Total Debt | 387.13B | 495.72B | 526.16B | 483.64B | 378.59B |
| Total Liabilities | 622.73B | 769.09B | 791.35B | 742.77B | 608.17B |
| Stockholders Equity | 431.38B | 454.59B | 425.66B | 440.38B | 407.05B |
Cash Flow | |||||
| Free Cash Flow | 12.45B | 4.41B | -2.65B | -110.82B | 46.80B |
| Operating Cash Flow | 69.84B | 69.45B | 55.09B | 89.66B | 107.73B |
| Investing Cash Flow | 52.52B | -46.05B | -52.43B | -198.38B | -79.59B |
| Financing Cash Flow | -134.46B | -43.16B | 7.18B | 71.11B | -20.88B |
Teijin Technical Analysis
Teijin Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $10.81B | 15.65 | 5.50% | 1.89% | 3.10% | -27.09% | |
64 Neutral | ¥232.14B | 8.21 | -17.62% | 4.14% | -2.64% | 167.02% | |
| $2.56B | 11.90 | 15.22% | 2.02% | ― | ― | ||
| $2.00B | 4.83 | 20.86% | 0.02% | ― | ― | ||
| €614.15M | 7.63 | 8.66% | 3.84% | ― | ― | ||
78 Outperform | ¥237.49B | 13.65 | 3.63% | 5.10% | 12.42% | ||
71 Outperform | ¥124.65B | 14.18 | 2.46% | -0.43% | 42.04% |
Teijin Corporate Events
Teijin Limited has announced the disposal of treasury shares as part of its Restricted Stock and Performance Share Units plans. This move aims to align with corporate governance and enhance corporate value creation over the medium to long term. The plans are designed to motivate directors and executives by linking compensation with company performance, thereby aligning their interests with stakeholders. The disposal involves a total of 171,088 shares, with a focus on strengthening the company’s executive compensation system globally.
The most recent analyst rating on (JP:3401) stock is a Hold with a Yen1280.00 price target. To see the full list of analyst forecasts on Teijin stock, see the JP:3401 Stock Forecast page.
Teijin Limited announced the results of its 159th Ordinary General Meeting of Shareholders, where all proposed resolutions were approved. Key changes include the transition to a company with an Audit & Supervisory Committee, amendments to the Articles of Incorporation, and the election of new directors. These changes aim to enhance governance and operational efficiency, potentially impacting the company’s strategic direction and stakeholder engagement.
The most recent analyst rating on (JP:3401) stock is a Hold with a Yen1280.00 price target. To see the full list of analyst forecasts on Teijin stock, see the JP:3401 Stock Forecast page.
Teijin Limited has announced a proposal to amend its Articles of Incorporation to transition from a company with a Board of Statutory Auditors to one with an Audit and Supervisory Committee. This move aims to strengthen corporate governance by establishing new provisions related to the Audit and Supervisory Committee and allowing greater delegation of decision-making to directors. The changes are expected to enhance operational efficiency and align with modern governance practices, potentially impacting stakeholders by improving oversight and accountability.
Teijin Limited announced a revision of its stock compensation plans for directors in line with its transition to a company with an Audit & Supervisory Committee. This change aims to align with global corporate governance standards and enhance the company’s executive compensation system, impacting directors with overseas roles and potentially increasing the company’s stock value.
Teijin Limited announced significant financial adjustments in its fourth-quarter results for the fiscal year ended March 2025, primarily due to impairment losses and extraordinary income and loss. The company recorded an impairment loss of 28 billion yen related to its diabetes treatments in Japan, which underperformed due to competitive pressures and anticipated drug price revisions. Additionally, Teijin resolved to transfer shares of its affiliate, Teijin Automotive Technologies NA Holdings, resulting in a loss on valuation of shares and provisions for doubtful accounts and guarantees. Despite these adjustments, the company’s annual financial forecast remains unchanged, with no impact on consolidated profit/loss for the fiscal year.
Teijin Limited reported its consolidated financial results for the fiscal year ending March 31, 2025, showing a revenue increase of 4.7% year-on-year to 1,005,471 million yen. Despite a significant operating loss, the company achieved a profit attributable to owners of the parent of 28,347 million yen, marking a turnaround from the previous year’s loss. The company also announced an increase in annual dividends, reflecting confidence in its financial health and commitment to shareholder returns.